Social Anxiety Disorder — D-Cycloserine and Virtual Reality Exposure Therapy
Citation(s)
Anderson P, Zimand E, Schmertz SK, Ferrer M Usability and utility of a computerized cognitive-behavioral self-help program for public speaking anxiety. Cognitive and Behavioral Practice 14(2):198-207. 2007.
Andrews G, Cuijpers P, Craske MG, McEvoy P, Titov N Computer therapy for the anxiety and depressive disorders is effective, acceptable and practical health care: a meta-analysis. PLoS One. 2010 Oct 13;5(10):e13196. doi: 10.1371/journal.pone.0013196.
Caplan SE Relations among loneliness, social anxiety, and problematic Internet use. Cyberpsychol Behav. 2007 Apr;10(2):234-42.
Christensen H, Griffiths KM, Jorm AF Delivering interventions for depression by using the internet: randomised controlled trial. BMJ. 2004 Jan 31;328(7434):265. Epub 2004 Jan 23.
Hofmann SG, Sawyer AT, Asnaani A D-cycloserine as an augmentation strategy for cognitive behavioral therapy for anxiety disorders: an update. Curr Pharm Des. 2012;18(35):5659-62. Review.
Hofmann SG Enhancing exposure-based therapy from a translational research perspective. Behav Res Ther. 2007 Sep;45(9):1987-2001. Epub 2007 Jun 17. Review.
Kadouri A, Corruble E, Falissard B The improved Clinical Global Impression Scale (iCGI): development and validation in depression. BMC Psychiatry. 2007 Feb 6;7:7.
Mattick RP, Clarke JC Development and validation of measures of social phobia scrutiny fear and social interaction anxiety. Behav Res Ther. 1998 Apr;36(4):455-70.
Spitzer RL, Kroenke K, Williams JB Validation and utility of a self-report version of PRIME-MD: the PHQ primary care study. Primary Care Evaluation of Mental Disorders. Patient Health Questionnaire. JAMA. 1999 Nov 10;282(18):1737-44.
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.
